TY  - GEN
AU  - Lin,Grant L
AU  - Wilson,Kelli M
AU  - Ceribelli,Michele
AU  - Stanton,Benjamin Z
AU  - Woo,Pamelyn J
AU  - Kreimer,Sara
AU  - Qin,Elizabeth Y
AU  - Zhang,Xiaohu
AU  - Lennon,James
AU  - Nagaraja,Surya
AU  - Morris,Patrick J
AU  - Quezada,Michael
AU  - Gillespie,Shawn M
AU  - Duveau,Damien Y
AU  - Michalowski,Aleksandra M
AU  - Shinn,Paul
AU  - Guha,Rajarshi
AU  - Ferrer,Marc
AU  - Klumpp-Thomas,Carleen
AU  - Michael,Sam
AU  - McKnight,Crystal
AU  - Minhas,Paras
AU  - Itkin,Zina
AU  - Raabe,Eric H
AU  - Chen,Lu
AU  - Ghanem,Reem
AU  - Geraghty,Anna C
AU  - Ni,Lijun
AU  - Andreasson,Katrin I
AU  - Vitanza,Nicholas A
AU  - Warren,Katherine E
AU  - Thomas,Craig J
AU  - Monje,Michelle
TI  - Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
SN  - 1946-6242
PY  - 2020///0911
KW  - Animals
KW  - Brain Neoplasms
KW  - drug therapy
KW  - Brain Stem Neoplasms
KW  - Cell Death
KW  - Cell Line, Tumor
KW  - Drug Evaluation, Preclinical
KW  - Drug Synergism
KW  - Female
KW  - Glioma
KW  - High-Throughput Screening Assays
KW  - methods
KW  - Humans
KW  - Lactones
KW  - pharmacology
KW  - Male
KW  - Metabolomics
KW  - Mice
KW  - Panobinostat
KW  - Pyrroles
KW  - Reproducibility of Results
KW  - Sequence Analysis, RNA
KW  - Transcription, Genetic
KW  - drug effects
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1126/scitranslmed.aaw0064
ER  -